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Wastewater is a potential treasure trove of chemicals that reflects
population behavior and health status. Wastewater-based epi-
demiology has been employed to determine population-scale
consumption of chemicals, particularly illicit drugs, across different
communities and over time. However, the sociodemographic or
socioeconomic correlates of chemical consumption and exposure are
unclear. This study explores the relationships between catchment
specific sociodemographic parameters and biomarkers in wastewa-
ter generated by the respective catchments. Domestic wastewater
influent samples taken during the 2016 Australian census weekwere
analyzed for a range of diet, drug, pharmaceutical, and lifestyle
biomarkers. We present both linear and rank-order (i.e., Pearson and
Spearman) correlations between loads of 42 biomarkers and census-
derived metrics, index of relative socioeconomic advantage and
disadvantage (IRSAD), median age, and 40 socioeconomic index for
area (SEIFA) descriptors. Biomarkers of caffeine, citrus, and dietary
fiber consumption had strong positive correlations with IRSAD,
while tramadol, atenolol, and pregabalin had strong negative
correlation with IRSAD. As expected, atenolol and hydrochlorothia-
zide correlated positively with median age. We also found specific
SEIFA descriptors such as occupation and educational attainment
correlating with each biomarker. Our study demonstrates that
wastewater-based epidemiology can be used to study sociodemo-
graphic influences and disparities in chemical consumption.
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Wastewater-based epidemiology (WBE) is a method of sys-tematically sampling and analyzing chemical residues in
wastewater influent to measure a population’s consumption of
or exposure to chemicals. Per-capita consumption of specific
chemicals can be estimated by normalizing biomarker concentra-
tions in wastewater to the volume of wastewater and size of the
contributing population (1). Chemicals commonly measured by
WBE include illicit drugs such as cocaine and methamphetamine
(2), licit drugs such as tobacco and caffeine (3), pharmaceuticals
(4), and personal-care products such as ultraviolet filters (5). Ex-
posure to chemicals such as endocrine disruptors (6) or flame
retardants (7) can also be measured, as can hydrophobic chemicals
which partition to particulate matter (8). There are also theoretical
prospects of measuring biomarkers of diet (9, 10).
Most WBE studies have compared chemical loads over time, or
between different communities, or some combination of the two.
Analysis of temporal trends can monitor population chemical con-
sumption or exposure over time, such as changes in drug use in
response to government interventions such as plain cigarette pack-
aging (11) or cannabis legalization (12). Spatial analyses can provide
insights into differences in population lifestyles or behavior, such as
the prevalence of illicit drug consumption in different countries (2).
WBE studies corroborate or validate their findings by compar-
ing wastewater results with independent measures of consumption
or exposure. In the case of chemical consumption, these measures
may consist of survey estimates of self-reported drug consumption,
illicit drug seizure rates, or pharmaceutical sales volumes. In the
case of exposures, they may include variations in environmental
pollen (13) or temperature (14). In this way, WBE has been used
to identify relationships between chemical consumption and en-
vironmental phenomena (15).
Two recent studies have explored the contribution of the social
determinants of health to WBE findings. In a temporal study in
Athens, major financial and healthcare sector difficulties between
2010 and 2014 coincided with increased use of benzodiazepines,
antidepressants, and illicit drugs and decreased use of antibiotics
and nonsteroidal antiinflammatory drugs (NSAIDs). The study
illustrated how a severe socioeconomic downturn was accompa-
nied by changes in proxy biomarkers of population mental health
(16). A study on different catchments serving the city of Beijing
showed that antibiotics and other pharmaceutical and personal-
care product (PPCP) loads correlated with population density
and housing indices, showing that PPCP consumption volume in
Beijing was associated with socioeconomic measures at a pop-
ulation level (17). These first WBE socioeconomic studies used
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broad, generic indicators of socioeconomic status (SES),
which result in highly specific case studies rather than more
generalized trends.
The use of validated and widely accepted socioeconomic
metrics, such as those used by government and sociodemographic
researchers, can improve the quality, interpretability, and trans-
disciplinary relevance of WBE studies. The Australian Bureau of
Statistics, for example, uses national census data to calculate var-
ious socioeconomic indexes for areas (SEIFA) descriptors. These
are measures of income, education, employment, housing, and
more. Selections of SEIFA descriptors have been used to generate
broad indicators of community-level SES such as the index of
relative socioeconomic advantage and disadvantage (IRSAD)
(18). IRSAD has been used in various peer-reviewed studies in
medical (19), environmental (20), public health (21), and behav-
ioral (22) disciplines.
The present study examined relationships between WBE
biomarkers and the population median age, average IRSAD, and
40 SEIFA descriptors (Table 1) for 22 wastewater treatment plant
(WWTP) catchments in Australia (Fig. 1). Specifically, the study
examined whether sociodemographic measures correlated with
consumption of food components, PPCPs, and licit and illicit drugs
by analyzing wastewater influent samples collected during the week
of the 2016 national census. Per-capita loads of each biomarker
were calculated for each WWTP catchment. Using data collected
from the same census and georeferencing software, the median age
(henceforth age), IRSAD, and SEIFA descriptors were calculated
for the population served by each WWTP catchment. We used this
to study the correlations between per-capita loads of WBE bio-
markers and IRSAD, age, and SEIFA descriptors.
Results and Discussion
The present paper focuses on 42 biomarkers which were measured
in wastewater above the limit of quantification with >80% fre-
quency (SI Appendix, Table S1). The concentrations of these
biomarkers in wastewater are shown in SI Appendix, Fig. S1. We
report correlations between per-capita normalized loads (hence-
forth loads) of these substances with catchment age, catchment
IRSAD, and SEIFA descriptors using Pearson (23) and Spearman
rank-order correlation (24) to capture both linear and nonlinear
correlations. Using the confusion matrix (25), a false positive de-
tection rate of 0.01% corresponded to jRj = 0.35 (SI Appendix,
Fig. S2), and we applied a more conservative significance threshold
of jRj = 0.5.
Vitamins. We measured biomarkers of vitamins B3, E, and B6
in wastewater to assess population dietary vitamin intake. Both
N-methyl-2-pyridone-5-carboxamide (2PY) and N-methyl-4-pyridone-
3-carboxamide (4PY) are formed from consumption of nicotinamide,
a major B3 vitamer (26, 27). α-Carboxyethyl hydrochroman (αCEHC)
is formed from the metabolism of α-tocopherol (28, 29), the
predominant form of vitamin E in dietary sources (30). Urinary
4-pyridoxic acid accounts for 40 to 60% of dietary vitamin
B6 intake (31) and is a marker of short-term vitamin B6 intake
(27, 32, 33).
We found significant linear correlations between all 4 vitamin
biomarkers, particularly between the vitamin B metabolites 2PY,
4PY, and 4-pyridoxic acid (Rs = 0.555 to 0.895; SI Appendix, Fig.
S3). This suggests that their relative intake is largely homoge-
neous within populations. The vitamin markers had insignificant
correlation with age, but 2PY (and to a lesser extent 4PY and 4-
pyridoxic acid) correlated significantly with IRSAD (RS = 0.611;
Fig. 2). αCEHC did not reach significant correlations with any
SEIFA descriptors (see Fig. 4). In contrast, all B vitamin bio-
markers were most correlated with HIGHRENT (R = 0.534 to
0.662, private dwellings paying >$470 per wk in rent) and had
negative correlation with descriptors of lower SES such as
DISABILITYU70 (people under 70 y of age with a disability) or
UNEMPLOYED (people in labor force and unemployed; Figs. 3
and 4). This agrees with the literature, as socioeconomically
disadvantaged groups are less likely to meet nutritional guide-
lines for micro- and macronutrients (34, 35) than advantaged
groups (36). Insignificant correlations between αCEHC and
sociodemographic measures may be due to the ubiquity of vita-
min E in a range of easily accessible foods such as oils (37, 38).
Interestingly, some vitamin biomarkers correlated significantly
with ENGLISHPOOR (RS = 0.427 to 0.608; Fig. 3 and SI Ap-
pendix, Fig. S6). This agrees with the trend of higher fruit and
vegetable intake among Australian residents born outside of
English-speaking countries (39).
Fiber and Citrus. We measured the lignan consumption biomarkers
enterodiol and enterolactone and the citrus consumption bio-
marker proline betaine. Small and medium cohort studies have
shown dose-dependent relationships between citrus consumption
and urinary proline betaine excretion (40–42). Enterodiol and
enterolactone form in the gut from the metabolism of the lignans
matairesinol and secoisolariciresinol, which is abundant in whole
grains, legumes, seeds, and fruits (43, 44). Both are urinary bio-
markers of dietary fiber and polyphenol consumption from
fruit and grains (45, 46) and are inversely associated with body
mass index (47). We considered proline betaine, enterodiol,
and enterolactone to be indicators of a healthy diet.
In our dataset, no food biomarker correlated with age, but all
correlated significantly with IRSAD (Fig. 2). Correlation between
the sister biomarkers enterodiol and enterolactone was strong
(RS = 0.886; SI Appendix, Fig. S4). Of all biomarkers in our study,
enterodiol had the highest correlations with IRSAD (RP = 0.626,
RS = 0.612; Fig. 2). Its greatest SEIFA correlates were
OCC_MANAGER (people employed as managers, RP = 0.758)
and NOYEAR12ORHIGHER (age >14 y and highest educational
attainment year/grade 11 or lower, RS = −0.720; Fig. 3). Likewise,
proline betaine was correlated with SEIFA descriptors related to
education, specifically ATUNI (age >14 y and attending university
or other tertiary institution, RS = 0.695) and CERTIFICATE
(RS = −0.608; Fig. 4). Socioeconomically disadvantaged groups
(including those in Australia) are less likely to purchase or con-
sume grains, fruit, vegetables, and other foods high in fiber than
socioeconomically advantaged groups (37–39, 48). Our results
agree with these and suggest education and occupation as im-
portant factors in diet disparity.
Caffeine. Dietary caffeine intake derives primarily from coffee and
tea in adult populations and soft drinks among adolescents (49). As
the caffeine content of coffee (especially espresso) is generally
severalfold greater than that for tea or soft drinks (49), we consider
coffee consumption to be the major source of caffeine and its
metabolite paraxanthine in wastewater. As expected, caffeine and
paraxanthine showed strong cross-correlations, and their correla-
tions with other biomarkers were very similar (SI Appendix, Figs.
S3 and S4). Both caffeine markers correlated significantly with the
markers of vitamin, citrus, and fiber consumption (RS = 0.645 to
0.960; SI Appendix, Fig. S3). This may suggest a population-level
association between consumption of caffeine and a diet rich in
vitamins, citrus, and fiber, perhaps reflecting different food choices
among populations with higher caffeine intake. Caffeine loads had
significant linear correlation with IRSAD (Fig. 2). Additionally,
caffeine and paraxanthine loads increased with HIGHRENT
(RP = 0.727, RP = 0.606) and decreased with CERTIFICATE
(age >14 y and highest level of education is an intermediate to
advanced level of vocational training, Rs = −0.659, Rs = −0.532;
Figs. 3 and 4). This suggests that caffeine consumption is associated
with aspects of financial capability and educational attainment.
Our results agree with an Australian dietary survey conducted in
2011 to 2012 (n = 6,232). Habitual consumers of espresso or
ground coffee lived in households with higher SES and consumed
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more dietary caffeine than those who consumed mix coffee or
instant coffee, or those not consuming coffee (50). Espresso and
ground coffee consumers were also more likely to have a bache-
lor’s degree or higher than other groups (50), which is analogous to
our findings with the SEIFA descriptors. Our findings also support
cohort studies which find higher caffeine consumption among
higher SES adolescents (51) and adults (52). Although this trend
may be reversed for specific demographics at risk for caffeine
abuse (53), our results suggest the prevailing population-scale
trend is a mild correlation between caffeine consumption and
IRSAD. We suggest that increased caffeine consumption in so-
cioeconomically advantaged groups may reflect 1) greater financial
freedom to indulge in caffeinated beverages (i.e., coffee) and/or 2)
cultural institutionalization of regular coffee drinking among
advantaged and/or educated populations.
Opioids. We analyzed the opioids methadone and its metabolite
2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), codeine,
morphine, oxycodone and its metabolite noroxycodone, and tramadol.
Codeine was the only opioid available over the counter (OTC)
during the time of sampling. Loads of codeine, oxycodone, and
noroxycodone were significantly correlated with each other (RS= 0.516
to 0.724; SI Appendix, Fig. S4). This reflects catchment-level polydrug
use and the coexcretion of oxycodone and noroxycodone fol-
lowing oxycodone consumption (54, 55). Similarly, methadone
and EDDP correlated (RS =0.948) as expected (SI Appendix, Fig. S3).
Table 1. SEIFA descriptors used in the present study
Descriptors IRSAD weighting Definition
ATSCHOOL NA People aged 15 y and over who are still attending secondary school
ATUNI 0.36 People aged 15 y and over at a university or other tertiary institution
CERTIFICATE −0.36 People aged 15 y and over whose highest level of education is a certificate III or IV qualification
(intermediate or advanced vocational training)
DEGREE NA People aged 15 y and over whose highest level of education is a bachelor degree or higher
DIPLOMA 0.5 People aged 15 y and over whose highest level of education is an advanced diploma or diploma
NOEDU −0.34 People aged 15 y and over who have no educational attainment
NOYEAR12ORHIGHER −0.85 People aged 15 y and over whose highest level of education is year (grade) 11 or lower
CHILDJOBLESS −0.76 Families with children under 15 y of age and jobless parents
DISABILTYU70 −0.69 People aged under 70 y who need assistance with core activities
ENGLISHPOOR NA People who do not speak English well or at all
FEWBED NA Classifiable occupied private dwellings with one or no bedrooms
HIGHBED 0.44 Occupied private dwellings with 4 or more bedrooms
GROUP NA Occupied private dwellings that are group occupied private dwellings
LONE NA Occupied private dwellings that are lone person occupied private dwellings
HIGHCAR NA Occupied private dwellings with 3 or more cars
NOCAR −0.33 Occupied private dwellings with no cars
HIGHMORTGAGE 0.72 Occupied private dwellings paying more than $2,800 per mo in mortgage
HIGHRENT 0.47 Occupied private dwellings paying more than $470 per wk in rent
LOWRENT −0.64 Occupied private dwellings paying less than $215 per wk in rent (excluding $0 per wk)
INC_LOW −0.89 People with stated annual household equalized income between $1 and $25,999
(approximately first and second deciles)
INC_HIGH 0.83 People with stated annual household equalized income greater than $78,000
(approximately ninth and tenth deciles)
NONET −0.78 Occupied private dwellings with no internet connection
OCC_DRIVERS −0.62 Employed people classified as machinery operators and drivers
OCC_LABOR −0.79 Employed people classified as laborers
OCC_MANAGER 0.47 Employed people classified as managers
OCC_PROF 0.71 Employed people classified as professionals
OCC_SKILL5 NA Employed people working in a Skill Level 5 occupation (commensurate with compulsory
secondary education, vocational Certificate I, or a short period of on-the-job training)
OCC_SKILL4 NA Employed people working in a Skill Level 4 occupation (commensurate with vocational
Certificate II or III or at least 1 y of relevant experience)
OCC_SKILL2 NA Employed people working in a Skill Level 2 occupation (commensurate with AQF Associate Degree,
Advanced Diploma or Diploma, or at least 3 y of relevant experience)
OCC_SKILL1 NA Employed people working in a Skill Level 1 occupation (commensurate with bachelor degree or
higher qualification, or at least 5 y of relevant experience)
ONEPARENT −0.65 Families that are one-parent families with dependent offspring only
OWNING NA Occupied private dwellings owning the dwelling they occupy without a mortgage
MORTGAGE NA Occupied private dwellings owning the dwelling they occupy with a mortgage
SEPDIVORCED −0.6 People aged 15 y and over who are separated or divorced
UNEMPLOYED −0.66 People (in the labor force) who are unemployed
UNEMPLOYED1 NA People aged 15 y and over who are unemployed
UNINCORP NA Owner of an unincorporated enterprise
OCC_SERVICE_L −0.54 Employed people classified as Low Skill Community and Personal Service Workers
OCC_SALES_L −0.32 Employed people classified as Low Skill Sales
OVERCROWD −0.33 Occupied private dwellings requiring one or more extra bedrooms (based on Canadian
National Occupancy Standard)
NA: not applicable. Details regarding variable composition can be found elsewhere (18).
21866 | www.pnas.org/cgi/doi/10.1073/pnas.1910242116 Choi et al.
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Morphine was the only opioid significantly correlating with age
(RS = 0.543; Fig. 2), which matches its primary use in chronic
pain which increases with age (56, 57). It should be noted that
morphine residues can also be present from the metabolism of
other opioids such as codeine and heroin (58). Significant cor-
relations with IRSAD were only seen for tramadol (RS = −0.701)
and codeine (RS = 0.539; Fig. 2), suggesting that a broad SES
indicator does not explain methadone, morphine, and oxycodone
consumption at a population scale. However, strength of corre-
lations was higher with specific socioeconomic descriptors. SEIFA
correlates of all opioids studied showed moderate to strong cor-
relations with descriptors of socioeconomic disadvantage, and
strong inverse correlations with SEIFA measures of socioeco-
nomic advantage (Fig. 4). As illustrated in Fig. 3, methadone loads
were slightly lower in catchments with fewer ENGLISHPOOR
(individuals with poor English-speaking ability) and more resi-
dents with limited educational attainment. Codeine loads were
lower in catchments with fewer HIGHMORTGAGE (private
dwellings paying more than $2,800 per mo in mortgage) and were
generally higher in catchments with more ONEPARENT (one-
parent families with dependent offspring only). Oxycodone loads
increased with the proportion of DISABILITYU70 and decreased
with increasing household income. Tramadol loads were lowest in
populations with greater percentage of skilled workers or a low
percentage of laborers. Overall, these results are in line with the
demographic correlates of opioid use. Opioid users are more
likely to be taking other opioids (54) and have other health and
lifestyle complications (59). In Australia, laborers and groups with
limited education are more likely to use opioids (60). Likewise, in
other countries opioid use is associated with limited educational
achievement, lower household income, and other substance abuse
behavior (61, 62), and these match our findings regarding the
SEIFA variables. However, methadone, codeine, (nor)oxycodone,
and tramadol use were not associated with catchment age, which
can be considered a proxy for algesia.
Antidepressants. We measured the antidepressants citalopram,
desvenlafaxine, its parent compound venlafaxine, mirtazapine,
and amitriptyline, all prescription pharmaceuticals with little
difference in price during the time of sampling. We considered
antidepressants as a proxy for psychological distress. All antide-
pressants tested had no significant association with age (SI Appendix,
Figs. S3 and S4). All antidepressants tested except citalopram had
significant inverse correlations with IRSAD (RS = −0.529 to
−0.701; Fig. 2). Interestingly, these antidepressants seemed to
diverge in terms of SEIFA correlates. Des/venlafaxine had stron-
gest positive correlations with OCC_LABOR (people employed as
laborers, RP = 0.629 and 0.549, respectively; Fig. 4) and significant
correlations with similar educational and occupation descriptors (SI
Appendix, Figs. S6 and S7). Amitriptyline was most influenced by
educational descriptors; NOYEAR12ORHIGHER (RP =0.770)
and DEGREE (age >14 y and highest educational attainment a
bachelor degree or higher, RS = −0.674; Fig. 2). In contrast, cit-
alopram had stronger correlations with social descriptors such as
LONE (private dwellings with one resident), SEPDIVORCED
(age >14 y and separated or divorced), and NONET (occupied
private dwellings with no internet) than with education and oc-
cupation descriptors (Fig. 4 and SI Appendix, Figs. S6 and S7),
hinting at a difference in demographics between des/venlafaxine,
amitriptyline, and citalopram consumers. In Australia between
2003 and 2005 there were significant associations between anti-
depressant use and lower SES among those aged ≥30 y but a
statistically insignificant trend in those aged 20 to 29 y and a re-
verse association in those under 19 y (63). The lack of a consistent
trend encompassing all age groups may explain why correlations
were not significant when correlated with IRSAD but significant
with SEIFA descriptors.
We found significant correlations between antidepressants and
methadone, codeine, morphine, tramadol, and pregabalin (SI
Appendix, Figs. S3 and S4). This may reflect individual and/or
population-scale polydrug use; patients prescribed opioids are
also often prescribed antidepressants (64), and Australian pre-
gabalin users often coingest opioids (65).
Anticonvulsants.We measured the anticonvulsants carbamazepine,
gabapentin, and pregabalin. Carbamazepine and gabapentin had
insignificant correlation with increasing age, and carbamazepine
also had insignificant correlations with decreasing IRSAD (SI
Appendix, Figs. S3 and S4). Pregabalin was significantly correlated
with increasing age (RP = 0.510) and decreasing IRSAD (RS =
−0.731; Fig. 2). Pregabalin correlated significantly with opioids and
antidepressants, and this was true to a lesser extent for carbamaz-
epine and gabapentin (SI Appendix, Figs. S3 and S4). These
findings are expected as anticonvulsants are also used to treat
neuropathic pain (66). The different anticonvulsants seem to be
associated with age, IRSAD, and other biomarkers of distress to
differing extents (SI Appendix, Figs. S3 and S4), suggesting
consumption of each is driven by different sociodemographic
drivers. Fig. 3 shows pregabalin loads were lowest in catchments
with greater proportion of the population with INC_HIGH
(household income in highest 2 deciles, RS = −0.767) and in catch-
ments with fewer DISABILITYU70 (RS = 0.745). The second
most positive and negative SEIFA correlates of pregabalin were
INC_LOW (household income in lowest 2 deciles, RS = 0.688)
and HIGHMORTGAGE (RS = −0.748), highlighting income
as an important factor for pregabalin use (SI Appendix, Figs.
S6 and S7).
Pregabalin and gabapentin abuse is of increasing public health
concern (67); pregabalin use in particular has also been linked to
increased suicide risk in Australia. The links between lower SES
and higher pregabalin use, as well as its correlation with opioids,
antidepressants, and atenolol are in agreement with trends ob-
served in Greece during a worsening social and financial crisis
(16). Therefore, opioids, antidepressants, anticonvulsants, and
atenolol may be considered proxies of socioeconomic distress.
Illicit Drugs.Methamphetamine is an illicit drug, and around 4%
of a dose of methamphetamine is excreted as amphetamine
(68). This seems to be reflected in the significant correlations
20
30
40
50
60
70
0 20 40 60 80 100
M
ed
ia
n 
ag
e
IRSAD(%)
KEY
1000k 100k 10k
Fig. 1. IRSAD and median age of catchments featured in this study. Each
catchment is depicted by a circle whose area represents its population size.
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between the 2 biomarkers (SI Appendix, Figs. S3 and S4).
Amphetamine can be sourced from both illicit and legal
sources, although licit usage is negligible at a population scale
(SI Appendix, Supplementary Information Text 1). Amphet-
amine and methamphetamine had insignificant correlations
with IRSAD and age (Fig. 2) but both had moderate inverse
correlations with SEIFA descriptors of socioeconomic disad-
vantage (Fig. 4). For example, methamphetamine consumption
was relatively lower in catchments with fewer OCC_SKILL5
(low-skilled workers, RP = 0.625; Fig. 3). Conversely, catch-
ments with more than 15% of the population with DIPLOMA
(highest educational attainment is a diploma) had relatively
low methamphetamine consumption (Fig. 3). The influence of
SES on methamphetamine use is multifaceted and difficult to
segregate by broad socioeconomic indices such as IRSAD and
age. However, the SEIFA descriptors best correlating with
their use are similar to demographic characteristics of known
meth/amphetamine users (69, 70).
Alcohol. Ethyl sulfate, a biomarker of ethanol (alcohol) con-
sumption (71), was not correlated with age (RP = −0.081) and
had insignificant correlation with IRSAD (RP = 0.449; Fig. 2).
This result agrees with an Australian dietary recall study (n =
9,345) conducted in 2011 to 2012 which found insignificant
difference between alcohol intake among SES quintiles and
most age groups (39). However, ethyl sulfate was significantly
correlated with HIGHRENT (RP = 0.716; Figs. 2 and 4) and
similar indicators of socioeconomic advantage such as INC_HIGH
(RP = 0.601) and OCC_MANAGER (RP = 0.537; SI Appendix,
Figs. S6), indicating higher alcohol consumption in these socio-
demographically advantaged groups.
Tobacco. The tobacco consumption markers hydroxycotinine,
cotinine, and nicotine all strongly correlated with each other (SI
Appendix, Figs. S3 and S4). This is expected, as hydroxycotinine and
cotinine are metabolites of nicotine and their excretion is relatively
consistent between individuals in urine (72). No tobacco bio-
markers significantly associated with catchment age or IRSAD (Fig.
2). However, with the exclusion of an outlier catchment, nicotine
had significant negative correlations with IRSAD (RP = −0.504; SI
Appendix, Supplementary Information Text 2). This suggests that
correlation between IRSAD and tobacco consumption is not robust
at a population scale. The Australian National Drug Strategy
Household Survey of 2016 found smoking prevalence in the
4PY (vitamin B3)
4PA (vitamin B6)
sucralose
paraxanthine
cephalexin
ibuprofen
cetirizine
saccharin
fexofenadine
αCEHC (vitamin E)
acesulfame
sulfamethoxazole
trimethoprim
nicotine
amphetamine
methamphetamine hydroxycotinine
cotinine
methadone
gabapentin
naproxen
noroxycodone
carbamazepine
venalfaxine
oxycodone
ethyl sulfate (alcohol)
EDDP
2PY (vitamin B3)
proline betaine (citrus)
enterodiol (fibre)
caffeine
hydrocholorothiazide
morphine
citalopram
atenolol
pregabalin
tramadol
desvenlafaxine
codeine
mirtazapine
amitryptyline
enterolactone (fibre)
positive correlation
with age
with IRSAD
negative correlation
with age
negative correlation
KEY Food & sweeteners
Recreational drugs
Nonrecreational drugs
Significance cutoff: |R| = 0.5
Fig. 2. Correlations (R, Pearson or Spearman) of biomarker with catchment median age and IRSAD. Each biomarker is plotted using the highest jRj value.
Biomarkers without significant correlations are faded. Amphetamine and methamphetamine are illicit drugs. R values are provided numerically in SI Ap-
pendix, Figs. S3 and S4. 4PA, 4-pyridoxic acid.
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lowest and highest IRSAD quintiles to be 20.0% and 9.3%,
respectively (73). Such a trend may have been difficult to detect
in free-living populations as they are not strictly segregated by
SES. Figs. 3 and 4 show hydroxycotinine and cotinine corre-
lated significantly with NONET (RS = 0.512 to 0.527). Inverse
correlations with MORTGAGE (dwellings occupied with a
mortgage) or ATSCHOOL (individuals aged 15 y or older at-
tending secondary school) were insignificant (RS = −0.472 to
−0.484). This suggests that tobacco use may be higher among
the socially isolated, and lower among the middle to upper-middle
class. These findings agree with studies in Australian and other
populations that found inverse correlations between nicotine use
and various proxies of SES (21, 74).
Nonsteroidal Antiinflammatory Drugs. We studied the OTC
NSAIDs ibuprofen and naproxen, which differ in their duration
of efficacy. The relatively short-acting ibuprofen is used to treat
acute pain, whereas naproxen is longer-acting and better suited to
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Fig. 3. Correlations of wastewater biomarker loads with catchment-specific SEIFA descriptors, whose definitions are provided in Table 1. For each biomarker,
SEIFA descriptors with the greatest positive (blue) and negative (black) R values are plotted. Linear or first-order regressions are shown for illustration
purposes. SEIFA descriptor definitions are provided in Table 1.
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treating chronic pain (75). Insignificant correlation (RP = 0.425)
between ibuprofen and naproxen (SI Appendix, Figs. S3) suggests
limited relationship between the use of these NSAIDs. Ibuprofen
loads were not correlated with age or IRSAD (Fig. 2), and cor-
relations with SEIFA descriptors were also insignificant (Fig. 4),
suggesting relatively uniform use across the sociodemographic
spectrum. In contrast, naproxen approached significant correlation
with age (RP = 0.425) but not IRSAD (Fig. 2 and SI Appendix,
Figs. S3) and was inversely correlated with ATSCHOOL (RP =
−0.619, people aged 15 y and over attending secondary school;
Fig. 4), suggesting lower use in populations with younger
people. Overall, our results suggest that naproxen use is slightly
lower in younger catchments, which agrees with its application
for chronic pain (75).
Antihistamines. Fexofenadine and cetirizine are both OTC an-
tihistamines used to treat allergy symptoms and can be con-
sidered biomarkers of population histamine burden in a WBE
context (76). Significant correlations between the antihista-
mines and hydroxycotinine and cotinine (SI Appendix, Figs.
S3 and S4) may reflect the greater prevalence of asthma among
individuals exposed to tobacco smoke (77, 78). Neither antihista-
mine was associated with age or IRSAD in our dataset (jRj =
0.05 to 0.384; Fig. 2). This is expected as general socioeconomic
indices are not a consistent correlate of allergic disease incidence
despite higher allergic disease incidence in urbanized pop-
ulations (77, 79, 80). Rather, environmental factors such as
pollen, dust, and dampness may be more important drivers of
allergic disease (77, 81).
Antihypertensives. Atenolol was significantly correlated with
increasing age (RP = 0.660) and decreasing IRSAD (RS = −0.657;
Fig. 2). This is anticipated since atenolol is a commonly prescribed
(82) beta blocker for hypertension (83). Atenolol loads decreased
with HIGHMORTGAGE (RS = −0.763) and increased with
NONET (RS = 0.803; Fig. 3). This confirms the expectation of a
higher prevalence of hypertension in older and socioeconomically
disadvantaged individuals (84, 85). Atenolol also had significant
correlations with several opioids and antidepressants (SI Appendix,
Figs. S3 and S4). This is consistent with greater use of analgesics
among older individuals and supports multiple cohort studies
which show depression increases the risk of hypertension (86).
Hydrochlorothiazide is an OTC diuretic often used as a first-line
treatment for hypertension. Like atenolol, hydrochlorothiazide
correlated with age, but it contrasts with atenolol in its lack of
significant correlation with IRSAD (Fig. 2) and lower correlations
with SEIFA descriptors (Fig. 4). This may reflect its use as a first-
line of treatment and therefore a more uniform use throughout
different sociodemographic groups.
Antibiotics. We measured markers of the antibiotics cephalexin
(a cephalosporin and broad-spectrum antibiotic), sulfamethoxazole
(a sulfonamide), and trimethoprim. Significant correlation between
sulfamethoxazole and trimethoprim (SI Appendix, Figs. S3 and S4)
reflects the fact that the 2 drugs are commonly prescribed in
combination for bacterial infections. No antibiotics had significant
correaltion with age or IRSAD (jRj = 0.006 to 0.280; Fig. 2). In
particular, sulfamethoxazole and trimethoprim had insignificant
correlation with SEIFA variables (jRj =0.161 to 0.300; Figs. 3 and
4). Our results suggest that sociodemographic factors have no
major bearing on antibiotic use (particularly sulfamethoxazole and
trimethoprim) at a population scale. The literature on antibiotic
use and sociodemographics is mixed; European studies have shown
SES may drive usage (87, 88), including use of cephalosporins,
sulfonamides, and trimethoprim (89). However, other studies in
Europe and the United States highlight physician density and re-
muneration as major predictors of antibiotic use (88, 90).
Sweeteners. Artificial sweeteners are found in beverages, condi-
ments, breads, cereals, dairy products, and pharmaceuticals (91).
We measured levels of acesulfame, saccharin, and sucralose. The
artificial sweeteners had insignificant correlations with age or
IRSAD (Fig. 2), with the strongest correlation being between
sucralose and age (RS = −0.445). Acesulfame in particular had
negligible correlations with age (RP = −0.164) and IRSAD (RS =
−0.065). Similarly, correlations between acesulfame and SEIFA
descriptors were insignificant (Figs. 3 and 4). Of the artificial
sweeteners, only sucralose reached significant correlation with a
SEIFA descriptor, OWNING (dwellings owned without a mort-
gage, RP = 0.538; Fig. 4). Our results suggest mildly lower saccharin
consumption among populations which are older but not socio-
economically disadvantaged. Results regarding acesulfame support
an earlier WBE study that found per-capita loads to have a strong
linear relationship (R2 = 0.995) with catchment population size of
10 WWTPs spread out over 4 Australian states and territories (92).
Assumptions and Limitations. This study has certain methodolog-
ical limitations. As the study deals with correlations between
sociodemographic outcomes and biomarkers, we assume that the
presence of a biomarker of consumption in the wastewater solely
Posi ve Type SEIFA descriptor Nega ve Type SEIFA descriptor
Hydroxyco nine 0.512 S NONET -0.472 P MORTGAGE
Co nine 0.527 S NONET -0.484 P ATSCHOOL
Nico ne 0.448 S NONET -0.482 P MORTGAGE
Paraxanthine 0.607 P HIGHRENT -0.524 S CERTIFICATE
Caffeine 0.727 P HIGHRENT -0.645 S CERTIFICATE
Ethyl sulfate 0.716 P HIGHRENT -0.483 S OCC_SKILL5
Amphetamine 0.542 S OCC_DRIVER -0.466 P OCC_PROF
Methamphetamine 0.625 P OCC_SKILL5 -0.575 P DIPLOMA
Methadone 0.616 S ENGLISHPOOR -0.657 S CERTIFICATE
EDDP 0.575 S ENGLISHPOOR -0.660 S CERTIFICATE
Codeine 0.495 P ONEPARENT -0.489 S HIGHMORTGAGE
Morphine 0.655 P LONE -0.629 P ATSCHOOL
Oxycodone 0.581 P DISABILITYU70 -0.474 S INC_HIGH
Noroxycodone 0.434 P DISABILITYU70 -0.404 S INC_HIGH
Tramadol 0.840 S OCC_LABOUR -0.818 S OCC_SKILL1
Desvenlafaxine 0.629 P OCC_LABOUR -0.586 S HIGHRENT
Venlafaxine 0.549 P OCC_LABOUR -0.508 S INC_HIGH
Citalopram 0.662 P LONE -0.491 P ATSCHOOL
Mirtazapine 0.632 P OCC_SKILL5 -0.576 S INC_HIGH
Amitriptyline 0.770 P -0.674 S DEGREE
Carbamazepine 0.485 P OCC_LABOUR -0.422 S HIGHMORTGAGE
Gabapen n 0.487 P UNINCORP -0.414 P HIGHBED
Pregabalin 0.745 S DISABILITYU70 -0.767 S INC_HIGH
Ibuprofen 0.467 P OCC_MANAGER -0.418 P UNEMPLOYED
Naproxen 0.613 P LONE -0.619 P ATSCHOOL
Fexofenadine 0.559 P UNINCORP -0.524 P OCC_SKILL4
Ce rizine 0.655 S OCC_MANAGER -0.630 S OCC_SKILL4
Atenolol 0.803 S NONET -0.763 S HIGHMORTGAGE
Hydrochlorthiazide 0.568 S SEPDIVORCED -0.553 S HIGHBED
Cephalexin 0.587 S ATUNI -0.518 S CERTIFICATE
Sulphamethoxazole 0.300 S OCCP_SKILL2 -0.277 P MORTGAGE
Trimethoprim 0.161 P LONE -0.217 S ATSCHOOL
Acesulfame 0.255 S OCC_DRIVER -0.311 S OCC_PROF
Saccharin 0.412 S OCC_MANAGER -0.410 S UNEMPLOYED1
Sucralose 0.292 P HIGHRENT -0.542 P OWNING
2PY 0.662 S HIGHRENT -0.689 S DISABILITYU70
4PY 0.608 S HIGHRENT -0.562 S CERTIFICATE
alpha-CEHC 0.476 S ENGLISHPOOR -0.386 P OCC_DRIVERS
4-Pyridoxic acid 0.534 P HIGHRENT -0.528 S UNEMPLOYED
Proline betaine 0.695 S ATUNI -0.608 S CERTIFICATE
Enterodiol 0.758 S OCC_MANAGER -0.720 S NOYEAR12ORHIGHER
Enterolactone 0.742 S HIGHRENT -0.737 S NOYEAR12ORHIGHER
NOYEAR12ORHIGHER
Fig. 4. Linear or first-order correlation coefficients (R) of normalized bio-
marker loads with SEIFA descriptors, whose definitions are supplied in Table
1. Correlation type is designated P (Pearson) or S (Spearman). The signifi-
cance cutoff was jRj = 0.5.
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reflects consumption by individuals. This is reasonable for bio-
markers such as antidepressants. It may be less accurate for illicit
drugs, which potentially may be discarded via the wastewater
stream, and for proline betaine, an osmolyte in citrus flesh, which
may enter the sewer system via food scraps or industrial processing
of citrus. However, the association of proline betaine with IRSAD
(Fig. 2) and ATUNI (Fig. 4) implies higher loads from metro-
politan catchments less likely to have wastewater input from food
processing industries. This suggests that industrial processing were
not a major issue in our study.
In-sewer transformation can affect some biomarkers. This
means that the load that enters the sewer system may differ from
the load sampled (93). In planning this study, we avoided mea-
suring biomarkers known to transform rapidly in sewer systems
such as paracetamol (94). The extent of in-sewer transformation is
catchment-specific and is not known for all chemicals tested in this
study, in some cases due to the novel nature of their application.
The loads of a biomarker in wastewater do not give insight into
the prevalence of its excretion in the population sampled. For
example, if different catchments have the same load of a bio-
marker, we cannot determine whether these communities have
the same number of people exposed at the same level or a fewer
number of people exposed at a higher level. This is a limitation
of the method but it is an advantage from an ethical viewpoint
because it ensures the anonymity of individuals in the catchment
area. Hall et al. (95) provide suggestions on how WBE studies
should be reported to avoid any adverse impacts on residents of
wastewater catchment areas.
Our wastewater samples came from 21.1% of the Australian
population. Our study was limited to catchments from where
samples were available and so is not a randomly selected subset of
the Australian population. Nevertheless, the selected locations
ensured that the proportion of the population in urban catchments
as compared to rural catchments in our dataset approximated to
the proportions in the overall Australian population.
The census-derived data used to calculate median age, IRSAD,
and SEIFA for the catchment areas were made available in
georeferenced mesh blocks. When the boundary of a WWTP
intersected mesh blocks, the proportion of area inside the WWTP
catchment was used to scale the mesh-block calculation. This
calculation assumed a uniform distribution of population inside
each mesh block, which is unlikely in most cases. Nevertheless,
these uncertainties are expected to be minimal as each mesh block
contains a relatively small number of people (96).
In terms of the correlation analysis, we used Pearson linear
correlation (i.e., parametric) and Spearman rank-order correlation
(i.e., nonparametric). The parametric approach is much more
sensitive to trends in the data but assumes a normal distribution
for the data. On the other hand, nonparametric methods (i.e.,
Spearman correlation) are less sensitive and do not assume any
data distribution. We combined the 2 methods rather than trans-
forming the data and using the parametric approach. Additionally,
our approach can only capture the direct bivariate correlation
between different descriptors; more sophisticated multivariate
methods would be able to isolate the associations with a combi-
nation of descriptors. Finally, the correlation coefficient threshold
for statistical significance was defined using the confusion matrix
approach (i.e., bootstrapping). This method only provides a
probability of false detection for each correlation coefficient value,
which has its own limitations (97).
Conclusion
This WBE study examined the relationship between WBE
biomarkers and sociodemographic descriptors. In general, vi-
tamin, citrus, and fiber consumption was associated with IRSAD
and educational descriptors, highlighting socioeconomic, educa-
tional, and occupational status as important factors in diet quality.
Conversely, lower IRSAD was associated with higher loads of tra-
madol, desvenlafaxine, mirtazapine, pregabalin, and atenolol. This
was consistent with higher pharmaceutical use in low SES groups.
Increasing population age was associated with morphine, cit-
alopram, atenolol, and hydrochlorothiazide, which may be
expected from their increase use among the elderly population.
Although WBE has primarily been used for measuring drug
consumption, our results demonstrate that it can be used to
identify sociodemographic patterns or disparities which associate
with consumption of specific chemicals or food components.
Materials and Methods
Wastewater samples analyzed in this study were collected from Australian
WWTPs as 7 consecutive daily samples taken around the time of the 2016
Australian census (9 August 2016) (96). Each sample was sampled flow- or
time-proportionally. The WWTP catchments were carefully selected to
maintain a ratio of urban and rural catchments representative of the greater
Australian population (Fig. 1). Twenty-two WWTPs from 6 states and terri-
tories were sampled that incorporated 21.1% of the Australian population.
Catchment populations ranged from 1,000 to 2.5 million (approximated for
anonymity). Five to seven consecutive 24-h composite samples, one of which
was collected on census day, were collected from the influent of each
WWTP. Each flow- or time-proportional sample was adjusted to pH 2 with
2 M HCl and frozen immediately after sampling. Samples were shipped
frozen to the laboratory on ice and stored at −20 °C until analysis. Each
sample was filtered with regenerated cellulose filters (0.2 μm; Agilent). One-
milliliter aliquots were spiked with internal standard to 10 μg/L for analysis.
Detailed sampling procedures are outlined elsewhere (96).
By sampling wastewater at the time of the census, wastewater samples
could be matched with sociodemographic data collected in the census.
Catchment populations were determined by overlaying georeferenced
WWTP catchment maps ontomesh blocks. Details of this methodology can be
found elsewhere (96). In brief, the population counts were summed within
each catchment area and allocated on a proportional-area basis for mesh-
block units which intersected the catchment boundary. When the boundary
of a WWTP intersected mesh blocks, the proportion of area inside the WWTP
catchment was used to scale the mesh-block calculation. This calculation
assumed uniform distribution of population inside each mesh block. Ne-
vertheless, uncertainties arising from these artifacts are expected to be
minimal as 99.9% of mesh blocks contain <500 people (96).
IRSAD is devised by the Australian Bureau of Statistics using a selection of
SEIFA descriptors to summarize the economic and social conditions of people
and households in the area by using descriptors that reflect relative socio-
economic advantage and disadvantage. A high IRSAD score indicates so-
cioeconomic advantage, and a low IRSAD score indicates socioeconomic
disadvantage. A full list of the SEIFA descriptors including the loadings of
descriptors used to form IRSAD can be found in Table 1. The technical paper
describing the construction of the IRSAD is available online (18). In our study,
average IRSAD was calculated specifically for each catchment in the same
way as age, but using Statistical Area level 1 (SA1) resolution (the second-
smallest census unit, typical population 200 to 800 people per unit). SEIFA
descriptors were calculated likewise using the SA1 resolution.
SI Appendix, Table S1 lists the Chemical Abstracts Service number and
standard manufacturer of each biomarker. All standards were of analytical
grade. Reagents used for the analysis were analytical-grade methanol from
Merck Pty Ltd and acetic acid from Sigma; HCl was from Merck Pty Ltd. Water
was purified using a MilliQ system (0.22-μm-filtered, 18.2 MΩ/cm; Millipore).
Biomarkers were quantified by isotope dilution or internal standards in
2 parallel liquid chromatography tandem mass spectrometry methods.
MethodAwas used tomeasuremostly illicit and licit drugs and is documented
elsewhere (98). Briefly, a Shimadzu Nexera UHPLC system housing a Phe-
nomenex Kinetex 2.6 μm Biphenyl (100 Å, 50- × 2.1-mm) column was con-
nected to an AB SCIEX QTRAP5500 operating in positive and negative
ionization modes. Chromatographic and transition details are provided in SI
Appendix, Table S2. The remaining biomarkers were analyzed using method
B, where a Shimadzu Nexera UHPLC system with a Kinetex 2.6 μm Biphenyl
(100 Å, 50- × 2.1-mm) column was connected to a Sciex 6500+ QTRAP mass
spectrometer. For both methods, an 8-point calibration series was used to
quantify chemicals using isotope dilution methods. A typical run featured
blanks and a QAQC sample every 6 to 8 samples. Performance and validation
details for method B are provided in SI Appendix, Tables S3–S5.
Biomarker loads in each sample were converted to milligrams per 24 h
per 1,000 people using census-derived populations for each WWTP
catchment. We did not perform any other data pretreatment in order to
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minimize the potential of false correlations caused by data pretreatment
processes.
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